
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.6B | -- | -- | $2.68 | -- |
07/30/2025 | Q2 | $1.7B | -- | -- | $3.30 | -- |
05/06/2025 | Q1 | $1.5B | $1.5B | $2.71 | $2.72 | -$0.01 |
02/04/2025 | Q4 | $1.7B | $1.7B | $5.11 | $3.26 | $1.85 |
11/05/2024 | Q3 | $1.5B | $1.5B | $5.32 | $2.37 | $2.95 |
07/30/2024 | Q2 | $1.6B | $1.6B | $2.93 | $3.03 | -$0.10 |
04/30/2024 | Q1 | $1.5B | $1.5B | $2.67 | $2.54 | $0.13 |
02/06/2024 | Q4 | $1.6B | $1.6B | $2.64 | $2.83 | -$0.19 |
11/03/2023 | Q3 | -- | -- | $2.26 | $1.96 | $0.30 |
08/01/2023 | Q2 | -- | -- | $2.48 | $2.50 | -$0.02 |
05/02/2023 | Q1 | -- | -- | $3.68 | $2.06 | $1.62 |
02/07/2023 | Q4 | -- | -- | $3.21 | $2.58 | $0.63 |
11/01/2022 | Q3 | -- | -- | $2.17 | $1.87 | $0.30 |
08/02/2022 | Q2 | -- | -- | $2.53 | $2.14 | $0.39 |
05/03/2022 | Q1 | -- | -- | $2.08 | $1.72 | $0.36 |
02/08/2022 | Q4 | -- | -- | $2.50 | $2.42 | $0.08 |
11/02/2021 | Q3 | -- | -- | $1.76 | $1.55 | $0.21 |
08/03/2021 | Q2 | -- | -- | $3.13 | $1.73 | $1.40 |
05/04/2021 | Q1 | -- | -- | $1.84 | $1.05 | $0.79 |
02/09/2021 | Q4 | -- | -- | $1.33 | $0.82 | $0.51 |
11/03/2020 | Q3 | -- | -- | $0.19 | $0.53 | -$0.34 |
08/04/2020 | Q2 | -- | -- | $0.61 | $0.81 | -$0.20 |
05/07/2020 | Q1 | -- | -- | $0.83 | $0.32 | $0.51 |
02/04/2020 | Q4 | -- | -- | $0.75 | $0.82 | -$0.07 |
10/31/2019 | Q3 | -- | -- | $0.46 | $0.43 | $0.03 |
07/30/2019 | Q2 | -- | -- | $1.13 | $1.18 | -$0.05 |
05/07/2019 | Q1 | -- | -- | $0.23 | $0.53 | -$0.30 |
02/05/2019 | Q4 | -- | -- | $0.92 | -- | -- |
11/01/2018 | Q3 | -- | -- | $0.13 | -- | -- |
08/01/2018 | Q2 | -- | -- | $0.50 | -- | -- |
05/08/2018 | Q1 | -- | -- | -$0.22 | -- | -- |
02/06/2018 | Q4 | -- | -- | $1.16 | -- | -- |
11/02/2017 | Q3 | -- | -- | -$0.53 | -- | -- |
08/08/2017 | Q2 | -- | -- | -$1.03 | -- | -- |
05/04/2017 | Q1 | -- | -- | $0.43 | -- | -- |
02/02/2017 | Q4 | -- | -- | $0.79 | -- | -- |
11/03/2016 | Q3 | -- | -- | $0.36 | -- | -- |
08/04/2016 | Q2 | -- | -- | $0.62 | -- | -- |
05/05/2016 | Q1 | -- | -- | $0.54 | -- | -- |
02/04/2016 | Q4 | -- | -- | $0.78 | -- | -- |
11/05/2015 | Q3 | -- | -- | $0.36 | -- | -- |
Gartner reported $1.5B worth of top line sales in its most recent quarter.
Gartner announced earnings per share of $2.71 which represents a miss of analyst forecast a $2.72 per share.
Gartner reported $1.1B that represents $13.61 per share over the last quarter.
Gartner's earnings are forecast to decrease from $16.00 per share to $11.90 per share next year representing a decrease of -22.09%.
Gartner's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.